These data demonstrate that the tumor cell mediated release of platelets ́ chemokines CXCL5 and CXCL7 is regulated by a juxtacrine dependent mechanism and the activation of the coagulation cascade, whereby the coagulation dependent part is susceptible to UFH inhibition (S3 Fig). Here, CXCL5 is linked to neoplasm.